Neurosurgery in a patient with severe hemophilia B: an experience using eftrenonacog alfa as perioperative management

Abstract

Abstract Extended half‐life FIX (EHL‐FIX) concentrates have been developed with the purpose of reducing the frequency of infusions in patients with severe or moderate hemophilia B. We describe the case of a 63‐year‐old patient with severe hemophilia B (sHB) treated with FIX‐Fc fusion protein (rFIXFc) who underwent neurosurgery.

Keywords

• anesthesia
• hematology
• neuosurgery
• pharmacology
• haemophilia B
• rFIX‐Fc